SAN FRANCISCO, CA / ACCESSWIRE / January 13, 2020 / Hagens Berman has filed a class action Complaint on behalf of investors in Aurora Cannabis Inc. (ACB). The firm urges ACB investors who have suffered losses in excess of $500,000 to submit their losses now to learn if they qualify to recover their investment losses.

Class Period: Oct. 23, 2018 - Jan. 6, 2020

Lead Plaintiff Deadline: Jan. 21, 2020

Sign Up: www.hbsslaw.com/investor-fraud/ACB
Contact An Attorney Now: ACB@hbsslaw.com
844-916-0895

Hagens Berman's Aurora Cannabis (ACB) Securities Class Action:

The Complaint is brought on behalf of all investors who purchased or otherwise acquired Aurora Cannabis securities during the Expanded Class Period - between Oct. 23, 2018 and Jan. 6, 2020, inclusive. The Complaint, filed in the United States District Court for the Southern District of New York and captioned Eaton v. Aurora Cannabis Inc., et al., (Case No. 1:20-cv-00274), pursues claims against the Defendants under the Securities Exchange Act of 1934 (the "Exchange Act").

According to the detailed Complaint filed by Hagens Berman, throughout the Extended Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Aurora had exaggerated and/or overestimated the demand for and potential market for its consumer use cannabis products; (ii) as a result, Aurora was overproducing consumer use cannabis products, leading to construction and production inefficiencies as well as the oversupply of products to its non-warehouse and warehouse customers; (iii) Aurora was utilizing an unpermitted, proprietary form of treatment in the production process of its medical Cannabis geared to obtain a longer shelf life of the products, which violates German law mandating that companies receive special permission to distribute medical products exposed to ionizing irradiation; and (iv) all of the foregoing was reasonably likely to have a material negative impact on the Company's financial results.

The Complaint alleges that the truth emerged through a series of disclosures occurring between Oct. 23, 2018 and Jan. 6, 2020, when the Company announced that it would be selling one of its largest greenhouses to raise cash.

As a result of these disclosures, the value of Aurora stock has consistently decreased, damaging investors.

"We're focused on recovering investors' losses and proving Aurora misled investors about its operations and growth initiatives," said Reed Kathrein, the Hagens Berman partner leading the investigation.